TrialBreast cancer research : BCR2012

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.

Shuzhen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.